Global Tourette Syndrome Drug Market Research Report 2023

The global Tourette Syndrome Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Tourette Syndrome Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Tourette Syndrome Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Tourette Syndrome Drug include Abide Therapeutics Inc, Catalyst Pharmaceuticals Inc, Neurocrine Biosciences Inc, Psyadon Pharmaceuticals Inc, Reviva Pharmaceuticals Inc, Synchroneuron Inc, Teva Pharmaceutical Industries Ltd and Therapix Biosciences Ltd, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Tourette Syndrome Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tourette Syndrome Drug.

The Tourette Syndrome Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tourette Syndrome Drug market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tourette Syndrome Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Tourette Syndrome Drug

1.2 Tourette Syndrome Drug Segment by Type

1.2.1 Global Tourette Syndrome Drug Market Value Comparison by Type (2023-2029)

1.2.2 AZD-5213

1.2.3 CPP-115

1.2.4 Dutetrabenazine ER

1.2.5 Ecopipam Hydrochloride

1.2.6 Others

1.3 Tourette Syndrome Drug Segment by Application

1.3.1 Global Tourette Syndrome Drug Market Value by Application: (2023-2029)

1.3.2 Research Center

1.3.3 Hospital

1.3.4 Clinic

1.3.5 Others

1.4 Global Tourette Syndrome Drug Market Size Estimates and Forecasts

1.4.1 Global Tourette Syndrome Drug Revenue 2018-2029

1.4.2 Global Tourette Syndrome Drug Sales 2018-2029

1.4.3 Global Tourette Syndrome Drug Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Tourette Syndrome Drug Sales Market Share by Manufacturers (2018-2023)

2.2 Global Tourette Syndrome Drug Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Tourette Syndrome Drug Average Price by Manufacturers (2018-2023)

2.4 Global Tourette Syndrome Drug Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Tourette Syndrome Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Tourette Syndrome Drug, Product Type & Application

2.7 Tourette Syndrome Drug Market Competitive Situation and Trends

2.7.1 Tourette Syndrome Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Tourette Syndrome Drug Players Market Share by Revenue

2.7.3 Global Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Tourette Syndrome Drug Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Tourette Syndrome Drug Global Tourette Syndrome Drug Sales by Region: 2018-2029

3.2.1 Global Tourette Syndrome Drug Sales by Region: 2018-2023

3.2.2 Global Tourette Syndrome Drug Sales by Region: 2024-2029

3.3 Global Tourette Syndrome Drug Global Tourette Syndrome Drug Revenue by Region: 2018-2029

3.3.1 Global Tourette Syndrome Drug Revenue by Region: 2018-2023

3.3.2 Global Tourette Syndrome Drug Revenue by Region: 2024-2029

3.4 North America Tourette Syndrome Drug Market Facts & Figures by Country

3.4.1 North America Tourette Syndrome Drug Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Tourette Syndrome Drug Sales by Country (2018-2029)

3.4.3 North America Tourette Syndrome Drug Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Tourette Syndrome Drug Market Facts & Figures by Country

3.5.1 Europe Tourette Syndrome Drug Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Tourette Syndrome Drug Sales by Country (2018-2029)

3.5.3 Europe Tourette Syndrome Drug Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Tourette Syndrome Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Tourette Syndrome Drug Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Tourette Syndrome Drug Sales by Country (2018-2029)

3.6.3 Asia Pacific Tourette Syndrome Drug Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Tourette Syndrome Drug Market Facts & Figures by Country

3.7.1 Latin America Tourette Syndrome Drug Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Tourette Syndrome Drug Sales by Country (2018-2029)

3.7.3 Latin America Tourette Syndrome Drug Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Tourette Syndrome Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Tourette Syndrome Drug Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Tourette Syndrome Drug Sales by Country (2018-2029)

3.8.3 Middle East and Africa Tourette Syndrome Drug Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Tourette Syndrome Drug Sales by Type (2018-2029)

4.1.1 Global Tourette Syndrome Drug Sales by Type (2018-2023)

4.1.2 Global Tourette Syndrome Drug Sales by Type (2024-2029)

4.1.3 Global Tourette Syndrome Drug Sales Market Share by Type (2018-2029)

4.2 Global Tourette Syndrome Drug Revenue by Type (2018-2029)

4.2.1 Global Tourette Syndrome Drug Revenue by Type (2018-2023)

4.2.2 Global Tourette Syndrome Drug Revenue by Type (2024-2029)

4.2.3 Global Tourette Syndrome Drug Revenue Market Share by Type (2018-2029)

4.3 Global Tourette Syndrome Drug Price by Type (2018-2029)

5.1 Global Tourette Syndrome Drug Sales by Application (2018-2029)

5.1.1 Global Tourette Syndrome Drug Sales by Application (2018-2023)

5.1.2 Global Tourette Syndrome Drug Sales by Application (2024-2029)

5.1.3 Global Tourette Syndrome Drug Sales Market Share by Application (2018-2029)

5.2 Global Tourette Syndrome Drug Revenue by Application (2018-2029)

5.2.1 Global Tourette Syndrome Drug Revenue by Application (2018-2023)

5.2.2 Global Tourette Syndrome Drug Revenue by Application (2024-2029)

5.2.3 Global Tourette Syndrome Drug Revenue Market Share by Application (2018-2029)

5.3 Global Tourette Syndrome Drug Price by Application (2018-2029)

6.1 Abide Therapeutics Inc

6.1.1 Abide Therapeutics Inc Corporation Information

6.1.2 Abide Therapeutics Inc Description and Business Overview

6.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Product Portfolio

6.1.5 Abide Therapeutics Inc Recent Developments/Updates

6.2 Catalyst Pharmaceuticals Inc

6.2.1 Catalyst Pharmaceuticals Inc Corporation Information

6.2.2 Catalyst Pharmaceuticals Inc Description and Business Overview

6.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio

6.2.5 Catalyst Pharmaceuticals Inc Recent Developments/Updates

6.3 Neurocrine Biosciences Inc

6.3.1 Neurocrine Biosciences Inc Corporation Information

6.3.2 Neurocrine Biosciences Inc Description and Business Overview

6.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Product Portfolio

6.3.5 Neurocrine Biosciences Inc Recent Developments/Updates

6.4 Psyadon Pharmaceuticals Inc

6.4.1 Psyadon Pharmaceuticals Inc Corporation Information

6.4.2 Psyadon Pharmaceuticals Inc Description and Business Overview

6.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio

6.4.5 Psyadon Pharmaceuticals Inc Recent Developments/Updates

6.5 Reviva Pharmaceuticals Inc

6.5.1 Reviva Pharmaceuticals Inc Corporation Information

6.5.2 Reviva Pharmaceuticals Inc Description and Business Overview

6.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Portfolio

6.5.5 Reviva Pharmaceuticals Inc Recent Developments/Updates

6.6 Synchroneuron Inc

6.6.1 Synchroneuron Inc Corporation Information

6.6.2 Synchroneuron Inc Description and Business Overview

6.6.3 Synchroneuron Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Synchroneuron Inc Tourette Syndrome Drug Product Portfolio

6.6.5 Synchroneuron Inc Recent Developments/Updates

6.7 Teva Pharmaceutical Industries Ltd

6.6.1 Teva Pharmaceutical Industries Ltd Corporation Information

6.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview

6.6.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Portfolio

6.7.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates

6.8 Therapix Biosciences Ltd

6.8.1 Therapix Biosciences Ltd Corporation Information

6.8.2 Therapix Biosciences Ltd Description and Business Overview

6.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Therapix Biosciences Ltd Tourette Syndrome Drug Product Portfolio

6.8.5 Therapix Biosciences Ltd Recent Developments/Updates

7.1 Tourette Syndrome Drug Industry Chain Analysis

7.2 Tourette Syndrome Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Tourette Syndrome Drug Production Mode & Process

7.4 Tourette Syndrome Drug Sales and Marketing

7.4.1 Tourette Syndrome Drug Sales Channels

7.4.2 Tourette Syndrome Drug Distributors

7.5 Tourette Syndrome Drug Customers

8.1 Tourette Syndrome Drug Industry Trends

8.2 Tourette Syndrome Drug Market Drivers

8.3 Tourette Syndrome Drug Market Challenges

8.4 Tourette Syndrome Drug Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Tourette Syndrome Drug Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Tourette Syndrome Drug Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Tourette Syndrome Drug Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Tourette Syndrome Drug Sales (K Pcs) of Key Manufacturers (2018-2023)

    Table 5. Global Tourette Syndrome Drug Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Tourette Syndrome Drug Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Tourette Syndrome Drug Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Tourette Syndrome Drug Average Price (USD/Pcs) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Tourette Syndrome Drug, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Tourette Syndrome Drug, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Tourette Syndrome Drug, Product Type & Application

    Table 12. Global Key Manufacturers of Tourette Syndrome Drug, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Tourette Syndrome Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tourette Syndrome Drug as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Tourette Syndrome Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Tourette Syndrome Drug Sales by Region (2018-2023) & (K Pcs)

    Table 18. Global Tourette Syndrome Drug Sales Market Share by Region (2018-2023)

    Table 19. Global Tourette Syndrome Drug Sales by Region (2024-2029) & (K Pcs)

    Table 20. Global Tourette Syndrome Drug Sales Market Share by Region (2024-2029)

    Table 21. Global Tourette Syndrome Drug Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Tourette Syndrome Drug Revenue Market Share by Region (2018-2023)

    Table 23. Global Tourette Syndrome Drug Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Tourette Syndrome Drug Revenue Market Share by Region (2024-2029)

    Table 25. North America Tourette Syndrome Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Tourette Syndrome Drug Sales by Country (2018-2023) & (K Pcs)

    Table 27. North America Tourette Syndrome Drug Sales by Country (2024-2029) & (K Pcs)

    Table 28. North America Tourette Syndrome Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Tourette Syndrome Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Tourette Syndrome Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Tourette Syndrome Drug Sales by Country (2018-2023) & (K Pcs)

    Table 32. Europe Tourette Syndrome Drug Sales by Country (2024-2029) & (K Pcs)

    Table 33. Europe Tourette Syndrome Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Tourette Syndrome Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Tourette Syndrome Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Tourette Syndrome Drug Sales by Region (2018-2023) & (K Pcs)

    Table 37. Asia Pacific Tourette Syndrome Drug Sales by Region (2024-2029) & (K Pcs)

    Table 38. Asia Pacific Tourette Syndrome Drug Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Tourette Syndrome Drug Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Tourette Syndrome Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Tourette Syndrome Drug Sales by Country (2018-2023) & (K Pcs)

    Table 42. Latin America Tourette Syndrome Drug Sales by Country (2024-2029) & (K Pcs)

    Table 43. Latin America Tourette Syndrome Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Tourette Syndrome Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Tourette Syndrome Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Tourette Syndrome Drug Sales by Country (2018-2023) & (K Pcs)

    Table 47. Middle East & Africa Tourette Syndrome Drug Sales by Country (2024-2029) & (K Pcs)

    Table 48. Middle East & Africa Tourette Syndrome Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Tourette Syndrome Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Tourette Syndrome Drug Sales (K Pcs) by Type (2018-2023)

    Table 51. Global Tourette Syndrome Drug Sales (K Pcs) by Type (2024-2029)

    Table 52. Global Tourette Syndrome Drug Sales Market Share by Type (2018-2023)

    Table 53. Global Tourette Syndrome Drug Sales Market Share by Type (2024-2029)

    Table 54. Global Tourette Syndrome Drug Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Tourette Syndrome Drug Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Tourette Syndrome Drug Revenue Market Share by Type (2018-2023)

    Table 57. Global Tourette Syndrome Drug Revenue Market Share by Type (2024-2029)

    Table 58. Global Tourette Syndrome Drug Price (USD/Pcs) by Type (2018-2023)

    Table 59. Global Tourette Syndrome Drug Price (USD/Pcs) by Type (2024-2029)

    Table 60. Global Tourette Syndrome Drug Sales (K Pcs) by Application (2018-2023)

    Table 61. Global Tourette Syndrome Drug Sales (K Pcs) by Application (2024-2029)

    Table 62. Global Tourette Syndrome Drug Sales Market Share by Application (2018-2023)

    Table 63. Global Tourette Syndrome Drug Sales Market Share by Application (2024-2029)

    Table 64. Global Tourette Syndrome Drug Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Tourette Syndrome Drug Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Tourette Syndrome Drug Revenue Market Share by Application (2018-2023)

    Table 67. Global Tourette Syndrome Drug Revenue Market Share by Application (2024-2029)

    Table 68. Global Tourette Syndrome Drug Price (USD/Pcs) by Application (2018-2023)

    Table 69. Global Tourette Syndrome Drug Price (USD/Pcs) by Application (2024-2029)

    Table 70. Abide Therapeutics Inc Corporation Information

    Table 71. Abide Therapeutics Inc Description and Business Overview

    Table 72. Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 73. Abide Therapeutics Inc Tourette Syndrome Drug Product

    Table 74. Abide Therapeutics Inc Recent Developments/Updates

    Table 75. Catalyst Pharmaceuticals Inc Corporation Information

    Table 76. Catalyst Pharmaceuticals Inc Description and Business Overview

    Table 77. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 78. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product

    Table 79. Catalyst Pharmaceuticals Inc Recent Developments/Updates

    Table 80. Neurocrine Biosciences Inc Corporation Information

    Table 81. Neurocrine Biosciences Inc Description and Business Overview

    Table 82. Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 83. Neurocrine Biosciences Inc Tourette Syndrome Drug Product

    Table 84. Neurocrine Biosciences Inc Recent Developments/Updates

    Table 85. Psyadon Pharmaceuticals Inc Corporation Information

    Table 86. Psyadon Pharmaceuticals Inc Description and Business Overview

    Table 87. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 88. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product

    Table 89. Psyadon Pharmaceuticals Inc Recent Developments/Updates

    Table 90. Reviva Pharmaceuticals Inc Corporation Information

    Table 91. Reviva Pharmaceuticals Inc Description and Business Overview

    Table 92. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 93. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product

    Table 94. Reviva Pharmaceuticals Inc Recent Developments/Updates

    Table 95. Synchroneuron Inc Corporation Information

    Table 96. Synchroneuron Inc Description and Business Overview

    Table 97. Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 98. Synchroneuron Inc Tourette Syndrome Drug Product

    Table 99. Synchroneuron Inc Recent Developments/Updates

    Table 100. Teva Pharmaceutical Industries Ltd Corporation Information

    Table 101. Teva Pharmaceutical Industries Ltd Description and Business Overview

    Table 102. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 103. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product

    Table 104. Teva Pharmaceutical Industries Ltd Recent Developments/Updates

    Table 105. Therapix Biosciences Ltd Corporation Information

    Table 106. Therapix Biosciences Ltd Description and Business Overview

    Table 107. Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 108. Therapix Biosciences Ltd Tourette Syndrome Drug Product

    Table 109. Therapix Biosciences Ltd Recent Developments/Updates

    Table 110. Key Raw Materials Lists

    Table 111. Raw Materials Key Suppliers Lists

    Table 112. Tourette Syndrome Drug Distributors List

    Table 113. Tourette Syndrome Drug Customers List

    Table 114. Tourette Syndrome Drug Market Trends

    Table 115. Tourette Syndrome Drug Market Drivers

    Table 116. Tourette Syndrome Drug Market Challenges

    Table 117. Tourette Syndrome Drug Market Restraints

    Table 118. Research Programs/Design for This Report

    Table 119. Key Data Information from Secondary Sources

    Table 120. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Tourette Syndrome Drug

    Figure 2. Global Tourette Syndrome Drug Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Tourette Syndrome Drug Market Share by Type in 2022 & 2029

    Figure 4. AZD-5213 Product Picture

    Figure 5. CPP-115 Product Picture

    Figure 6. Dutetrabenazine ER Product Picture

    Figure 7. Ecopipam Hydrochloride Product Picture

    Figure 8. Others Product Picture

    Figure 9. Global Tourette Syndrome Drug Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 10. Global Tourette Syndrome Drug Market Share by Application in 2022 & 2029

    Figure 11. Research Center

    Figure 12. Hospital

    Figure 13. Clinic

    Figure 14. Others

    Figure 15. Global Tourette Syndrome Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Tourette Syndrome Drug Market Size (2018-2029) & (US$ Million)

    Figure 17. Global Tourette Syndrome Drug Sales (2018-2029) & (K Pcs)

    Figure 18. Global Tourette Syndrome Drug Average Price (USD/Pcs) & (2018-2029)

    Figure 19. Tourette Syndrome Drug Report Years Considered

    Figure 20. Tourette Syndrome Drug Sales Share by Manufacturers in 2022

    Figure 21. Global Tourette Syndrome Drug Revenue Share by Manufacturers in 2022

    Figure 22. The Global 5 and 10 Largest Tourette Syndrome Drug Players: Market Share by Revenue in 2022

    Figure 23. Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 24. Global Tourette Syndrome Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 25. North America Tourette Syndrome Drug Sales Market Share by Country (2018-2029)

    Figure 26. North America Tourette Syndrome Drug Revenue Market Share by Country (2018-2029)

    Figure 27. U.S. Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. Canada Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. Europe Tourette Syndrome Drug Sales Market Share by Country (2018-2029)

    Figure 30. Europe Tourette Syndrome Drug Revenue Market Share by Country (2018-2029)

    Figure 31. Germany Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. France Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. U.K. Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Italy Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Russia Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Asia Pacific Tourette Syndrome Drug Sales Market Share by Region (2018-2029)

    Figure 37. Asia Pacific Tourette Syndrome Drug Revenue Market Share by Region (2018-2029)

    Figure 38. China Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Japan Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. South Korea Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. India Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Australia Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Taiwan Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Indonesia Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Thailand Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Malaysia Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Philippines Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Latin America Tourette Syndrome Drug Sales Market Share by Country (2018-2029)

    Figure 49. Latin America Tourette Syndrome Drug Revenue Market Share by Country (2018-2029)

    Figure 50. Mexico Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Brazil Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Argentina Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Middle East & Africa Tourette Syndrome Drug Sales Market Share by Country (2018-2029)

    Figure 54. Middle East & Africa Tourette Syndrome Drug Revenue Market Share by Country (2018-2029)

    Figure 55. Turkey Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 56. Saudi Arabia Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 57. UAE Tourette Syndrome Drug Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 58. Global Sales Market Share of Tourette Syndrome Drug by Type (2018-2029)

    Figure 59. Global Revenue Market Share of Tourette Syndrome Drug by Type (2018-2029)

    Figure 60. Global Tourette Syndrome Drug Price (USD/Pcs) by Type (2018-2029)

    Figure 61. Global Sales Market Share of Tourette Syndrome Drug by Application (2018-2029)

    Figure 62. Global Revenue Market Share of Tourette Syndrome Drug by Application (2018-2029)

    Figure 63. Global Tourette Syndrome Drug Price (USD/Pcs) by Application (2018-2029)

    Figure 64. Tourette Syndrome Drug Value Chain

    Figure 65. Tourette Syndrome Drug Production Process

    Figure 66. Channels of Distribution (Direct Vs Distribution)

    Figure 67. Distributors Profiles

    Figure 68. Bottom-up and Top-down Approaches for This Report

    Figure 69. Data Triangulation

    Figure 70. Key Executives Interviewed